ELVN vs. EQT

Last updated Jun 4, 2026

ELVN (Enliven Therapeutics Inc.) and EQT (EQT Corporation) are both stocks. ELVN operates in Biotechnology (Healthcare), while EQT operates in Oil & Gas E&P (Energy). Over the past 5 years, ELVN returned 2.00%/yr vs 22.14%/yr for EQT. At a 0.14 correlation, their price movements are largely independent.

Performance

ELVN vs. EQT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enliven Therapeutics Inc. (ELVN) and EQT Corporation (EQT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ELVN achieves a 133.96% return, which is significantly higher than EQT's 2.20% return.

ELVN

• 1D: 1.44%
• 1M: -13.41%
• YTD: 133.96%
• 6M: 71.57%
• 1Y: 64.82%
• 3Y*: 18.69%
• 5Y*: 2.00%
• 10Y*: —

EQT

• 1D: -0.38%
• 1M: -7.54%
• YTD: 2.20%
• 6M: -10.45%
• 1Y: -2.72%
• 3Y*: 15.86%
• 5Y*: 22.14%
• 10Y*: 4.02%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ELVN vs. EQT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
ELVN Enliven Therapeutics Inc.	133.96%	-31.56%	62.57%	-15.40%	81.78%	-89.80%	47.00%
EQT EQT Corporation	2.20%	17.64%	21.41%	16.20%	57.64%	71.60%	83.14%

Correlation

The correlation between ELVN and EQT is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Mar 13, 2020	0.14

The correlation between ELVN and EQT shifts across timeframes, from -0.01 (1 year) to 0.15 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ELVN : $2.26B EQT : $34.05B
EPS ELVN : -$1.69 EQT : $5.40
PB Ratio ELVN : 4.99 EQT : 1.36
Total Revenue (TTM) ELVN : $0.00 EQT : $10.03B
Gross Profit (TTM) ELVN : -$46.00K EQT : $6.43B
EBITDA (TTM) ELVN : -$110.65M EQT : $7.48B

Return for Risk

ELVN vs. EQT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELVN

ELVN Risk / Return Rank: 71
ELVN Sharpe Ratio Rank: 67
ELVN Sortino Ratio Rank: 74
ELVN Omega Ratio Rank: 69
ELVN Calmar Ratio Rank: 72
ELVN Martin Ratio Rank: 74

EQT

EQT Risk / Return Rank: 34
EQT Sharpe Ratio Rank: 37
EQT Sortino Ratio Rank: 32
EQT Omega Ratio Rank: 31
EQT Calmar Ratio Rank: 35
EQT Martin Ratio Rank: 36

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELVN vs. EQT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enliven Therapeutics Inc. (ELVN) and EQT Corporation (EQT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ELVN	EQT	Difference
Sharpe ratio Return per unit of total volatility	0.80	-0.08	+0.89
Sortino ratio Return per unit of downside risk	1.94	0.11	+1.83
Omega ratio Gain probability vs. loss probability	1.22	1.01	+0.20
Calmar ratio Return relative to maximum drawdown	1.77	-0.14	+1.91
Martin ratio Return relative to average drawdown	4.61	-0.25	+4.87
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ELVN vs. EQT - Sharpe Ratio Comparison

The current ELVN Sharpe Ratio is 0.80, which is higher than the EQT Sharpe Ratio of -0.08. The chart below compares the historical Sharpe Ratios of ELVN and EQT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ELVN	EQT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.80	-0.08	+0.89
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.02	0.52	-0.50
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.08	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.30	-0.39

Drawdowns

ELVN vs. EQT - Drawdown Comparison

The maximum ELVN drawdown since its inception was -98.20%, which is greater than EQT's maximum drawdown of -91.51%. Use the drawdown chart below to compare losses from any high point for ELVN and EQT.

Drawdown Indicators

	ELVN	EQT	Difference
Max Drawdown Largest peak-to-trough decline	-98.20%	-91.51%	-6.69%
Max Drawdown (1Y) Largest decline over 1 year	-36.84%	-19.59%	-17.25%
Max Drawdown (3Y) Largest decline over 3 years	-56.05%	-31.62%	-24.43%
Max Drawdown (5Y) Largest decline over 5 years	-89.05%	-42.56%	-46.49%
Max Drawdown (10Y) Largest decline over 10 years	—	-88.28%	—
Current Drawdown Current decline from peak	-83.58%	-19.59%	-63.99%
Average Drawdown Average peak-to-trough decline	-84.22%	-23.34%	-60.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.09%	10.88%	+3.21%

Volatility

ELVN vs. EQT - Volatility Comparison

Enliven Therapeutics Inc. (ELVN) has a higher volatility of 14.50% compared to EQT Corporation (EQT) at 7.67%. This indicates that ELVN's price experiences larger fluctuations and is considered to be riskier than EQT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ELVN	EQT	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.50%	7.67%	+6.83%
Volatility (6M) Calculated over the trailing 6-month period	60.61%	21.75%	+38.86%
Volatility (1Y) Calculated over the trailing 1-year period	82.50%	32.54%	+49.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	85.81%	42.80%	+43.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	87.95%	48.92%	+39.03%

Dividends

ELVN vs. EQT - Dividend Comparison

ELVN has not paid dividends to shareholders, while EQT's dividend yield for the trailing twelve months is around 1.20%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ELVN Enliven Therapeutics Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EQT EQT Corporation	1.20%	1.19%	1.37%	1.57%	1.63%	0.00%	0.24%	1.10%	0.42%	0.21%	0.18%	0.23%

Financials

Frequently Asked Questions

Can I hold both ELVN and EQT in my portfolio?

ELVN and EQT have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ELVN or EQT?

ELVN has higher volatility (14.50%) compared to EQT (7.67%). In terms of maximum drawdown, ELVN dropped -98.20% vs EQT's -91.51%.

Which has better risk-adjusted returns?

ELVN currently has the higher Sharpe Ratio (0.80 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.